Crystal Adam
SEC insider (Form 3/4/5 filer). CIK 0001825445. President, R&D at Tango Therapeutics, Inc. (TNGX). 31 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in BOSTON, MA.
Companies Crystal Adam has filed insider reports for
- Tango Therapeutics, Inc. (TNGX): Officer, President, R&D
Crystal Adam
CIK: 0001825445
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tango Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Oct 1, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect600 shares at avg. $25.32$15K - Oct 1, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect26.4K shares at avg. $24.45$646K - Oct 1, 2026TNGX
Tango Therapeutics, Inc.
ExerciseDirect27K shares at avg. $5.20$140K - Sep 1, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect27K shares at avg. $22.37$604K - Sep 1, 2026TNGX
Tango Therapeutics, Inc.
ExerciseDirect27K shares at avg. $5.20$140K - Aug 3, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect5.3K shares at avg. $26.79$141K - Aug 3, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect21.7K shares at avg. $27.35$594K - Aug 3, 2026TNGX
Tango Therapeutics, Inc.
ExerciseDirect27K shares at avg. $5.20$140K - Jul 1, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect19.6K shares at avg. $29.34$576K - Jul 1, 2026TNGX
Tango Therapeutics, Inc.
ExerciseDirect27K shares at avg. $5.20$140K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | TNGX Tango Therapeutics, Inc. | Sale | 600 | $25.32 | $15,192 | Direct |
| Oct 1, 2026 | TNGX Tango Therapeutics, Inc. | Sale | 26,400 | $24.45 | $645,604 | Direct |
| Oct 1, 2026 | TNGX Tango Therapeutics, Inc. | Exercise | 27,000 | $5.20 | $140,400 | Direct |
| Sep 1, 2026 | TNGX Tango Therapeutics, Inc. | Sale | 27,000 | $22.37 | $603,909 | Direct |
| Sep 1, 2026 | TNGX Tango Therapeutics, Inc. | Exercise | 27,000 | $5.20 | $140,400 | Direct |
| Aug 3, 2026 | TNGX Tango Therapeutics, Inc. | Sale | 5,267 | $26.79 | $141,100 | Direct |
| Aug 3, 2026 | TNGX Tango Therapeutics, Inc. | Sale | 21,733 | $27.35 | $594,417 | Direct |
| Aug 3, 2026 | TNGX Tango Therapeutics, Inc. | Exercise | 27,000 | $5.20 | $140,400 | Direct |
| Jul 1, 2026 | TNGX Tango Therapeutics, Inc. | Sale | 19,629 | $29.34 | $575,962 | Direct |
| Jul 1, 2026 | TNGX Tango Therapeutics, Inc. | Exercise | 27,000 | $5.20 | $140,400 | Direct |
1-10 of 31 transactions